Stefano Palea

IRDI Capital Investissement SAS(IRDI Capital) is an independent French regional venture capital/private equity firm which was established in 1981 by Alain Savary. The firm is headquartered in Toulouse.

Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector.

Sud Ouest Capital Risque Innovation SAS invests in innovative companies established in the Aquitaine and Midi-Pyrénées regions. The fund invests in the range of €150,000 - €1 million per transaction and also makes co-investments.

EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.

IXO Private Equity SAS (IXO-PE) is an independent France-based regional private equity firm which was founded in 2002. Headquartered in Toulouse with an office in Bordeaux, the firm was previously known as ICSO Gestion. Their culture emphasizes regional development and local employment creation. The firm manages FCPR limited partnership venture capital funds for institutions and FIP regional development funds for individual investors. IXO-PE's institutional clients include local collectivities, insurance companies and international corporations as well as regional, national and European banks.

Xyence Capital SGR (Xyence Capital) is a venture capital firm founded in 2002 by Stefano Peroncini and Pierluigi Paracchi. The firm is headquartered in Milano, Italy.

ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France.

Lifandis AS provides access to a wealth of biological samples. It offers data and biological material from the HUNT studies. The company was founded in 2007 and is headquartered in Levanger, Norway.

Comecer SpA develops and manufactures aseptic processing and containment systems. Its technologies offers solutions in the fields of radiopharmacy, pharmacy, and advanced therapy medicinal products. The company was founded by Carlo Zanelli in 1974 and is headquartered in Castel Bolognese, Italy.

Consiglio Nazionale delle Ricerche provides scientific and technological research services. The company was founded on November 18, 1923 and is headquartered in Rome, Italy.

APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway.

Medicon Valley Alliance FMBA operates a life science cluster that spans across Denmark and Sweden. The non-profit company is based in the Medicon Valley region.

Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands.

Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France.

GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France.

WISE Srl operates as a biomedical company which engages in the development of neuromodulation and neuromonitoring devices. It offers scbi technology, stretchability, micropatterning, biocompatibility and effective stimulation. The company was founded by Cristian Ghisleri, Luca Ravagnan, Mario Zanone Poma and Paolo Milani in 2011 and is headquartered in Cologno Monzese, Italy.

Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France.

Ffly4u SASU provides a low frequency localization services for mobile assets. It also offers services like movement, temperature, noise or opening detection in order to guarantee the integrity of sensitive assets. The company was founded by Pages Olivier in 2015 and is headquartered in Toulouse, France.

FineHeart SA manufactures medical devices for cardiovascular space. It offers wirelessly powered and fully-implantable mechanical circulatory support device. The company was founded by Stéphane Garrigue and Philippe Ritter on January 13, 2010 and is headquartered in Pessac, France.

EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France.

Tritone Mare di Galeotti Marco & C. SNC operates restaurants. The private company is based in Sarzana, Italy.

Rigenerand Srl operates as a biotechnology company. It develops and produces biomedical devices that support the culture of stem cells for pre-clinical and clinical applications. The company was founded by Massimo Dominici and Pierfranco Conte in 2009 and is headquartered in Medolla, Italy.

Backbone SAS is a venture capital and private equity firm. It specializes in investments in late venture companies, startups, buyouts, growth financing, leveraged buyouts, and buyins. The company was founded by Nazanine Sahami on March 25, 2015 and is headquartered in Le Bouscat, France.

Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA.

MicroPEP Technologies SAS engages in the development of biomimetic peptides that manage plant genetics. The company was founded by Thomas Laurent on April 15, 2016 and is headquartered in Toulouse, France.

EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium.

Gada SpA is a holding company, which engages in the provision of integrated healthcare solutions. It offers cardiovascular, blood and infusion management, and intensive care services. The company was founded in 1978 and is headquartered in Rome, Italy.

TreeFrog Therapeutics SAS provides stem cell treatment services. It offers its expertise to patients of heart failure, diabetes, traumatic injury, skin burns, dermatitis, Huntington, and Parkinson disease. The company was founded by Maxime Feyeux, Kevin Alessandri, Jean-Luc Treillou, Erwan Bezard, Laurent Cognet, and Pierre Nassoy and is headquartered in Pessac, France.

Orbit Genomics, Inc. operates as a technology platform for early disease detection, treatment, and prevention of diseases. The company is based in Boulder, CO. The company was founded by Elizabeth Willis, Harold Garner. Elizabeth Willis has been the CEO since incorporation.

Swallis Medical SAS engages in the provision of diagnostic and monitoring solutions for problem of swallowing disorders. The company was founded by Linda Nicolini in 2019 and is headquartered in Toulouse, France.

Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France.

IRDInov SAS functions as an investment holding French company. The private company is based in Paris, France.

LDL Technology SAS designs, manufactures and develops wireless embedded electronic systems. Its technologies include tire pressure monitoring systems, vehicle immobilization, keyless entry and start system, and body control units. The company was founded by Dominique Luce and Philippe Lefaure on June 30, 2004 and is headquartered in Ramonville-Saint-Agne, France.